Negocie AbbVie ABBV

Venda
 Comprar

Gráfico AbbVie ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Últimas notícias

Tommy Yap 2025 Mar 26, 16:00

Morning Note: U.S. GDP, Canada Inflation & SEC Crypto-Friendly Plans

Morning Note USD CAD Cryptocurrencies
Frances Wang 2025 Mar 25, 16:00

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Fed
Tommy Yap 2025 Mar 25, 16:00

Morning Note: S&P 500 Surges on Tariff Optimism as Tesla Jumps 10%

Morning Note S&P 500 TSLA Oil
Tommy Yap 2025 Mar 25, 16:00

Morning Note: Australia’s Inflation Cools, Japan’s Stays High, UK Awaits Data

Morning Note AUD USD JPY GBP
Frances Wang 2025 Mar 24, 16:00

Pepe coin news today: where will Pepe coin price go in 2025?

Cryptocurrencies
Frances Wang 2025 Mar 24, 16:00

USD/JPY news today: Will USD/JPY Break 150?

Forex
Tommy Yap 2025 Mar 23, 16:00

Morning Note: Nvidia’s $1 Trillion Data Centre Bet, SEC Crypto Rules, US PMI Data

Morning Note NVDA Cryptocurrencies CPI
Tommy Yap 2025 Mar 22, 16:00

Week Ahead: Investor Eyes on U.S. Inflation & Core PCE for Fed’s Next Move

Forex Indices

Info

Spread

1.35

Spread (%)

0.6727 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Quinta-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

356166434816

Ações em circulação

1768979968

Data dos rendimentos (Próxima)

0000-00-00

Rendim Divid

2025-05-15

Data Ex-Dividendos

2025-04-15

Taxa anual futura de dividendos

6.56

Rendimento anual futuro de dividendos

0.0326

EPS

2.4

Saiba mais sobre este instrumento

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados
Trustpilot